Which of these medical products was recalled within a year of launch due to serious safety concerns, costing its manufacturer over $1 billion in losses?

Even the most promising medical products don't always succeed in the market. This poll tests your knowledge about notable product failures in the medical and pharmaceutical industry. Do you know which highly anticipated medical innovation didn't live up to expectations despite significant investment and initial enthusiasm?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vioxx (rofecoxib) by Merck, a pain medication that increased heart attack and stroke risk
Daraprim by Turing Pharmaceuticals, which failed due to manufacturing contamination issues
Exubera by Pfizer, an inhaled insulin that was pulled due to radioactive components
Theranos' Edison blood testing device, which was recalled after FDA safety violations